Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Laird Cameron"'
Autor:
Tamsin J. Robb, Yinan Liu, Braden Woodhouse, Charlotta Windahl, Daniel Hurley, Grant McArthur, Stephen B. Fox, Lisa Brown, Parry Guilford, Alice Minhinnick, Christopher Jackson, Cherie Blenkiron, Kate Parker, Kimiora Henare, Rose McColl, Bianca Haux, Nick Young, Veronica Boyle, Laird Cameron, Sanjeev Deva, Jane Reeve, Cristin G. Print, Michael Davis, Uwe Rieger, Ben Lawrence
Publikováno v:
npj Digital Medicine, Vol 7, Iss 1, Pp 1-6 (2024)
Abstract We introduce a proof-of-concept extended reality (XR) environment for discussing cancer, presenting genomic information from multiple tumour sites in the context of 3D tumour models generated from CT scans. This tool enhances multidisciplina
Externí odkaz:
https://doaj.org/article/ed44e8f216c04158b220078ef64c705e
Autor:
Phyu Sin Aye, Joanne Barnes, George Laking, Laird Cameron, Malcolm Anderson, Brendan Luey, Stephen Delany, Dean Harris, Blair McLaren, Elliott Brenman, Jayden Wong, Ross Lawrenson, Michael Arendse, Sandar Tin Tin, Mark Elwood, Philip Hope, Mark James McKeage
Publikováno v:
JMIR Research Protocols, Vol 13, p e51381 (2024)
BackgroundStarting in 2010, the epidermal growth factor receptor (EGFR) kinase inhibitors erlotinib and gefitinib were introduced into routine use in Aotearoa New Zealand (NZ) for treating advanced lung cancer, but their impact in this setting is unk
Externí odkaz:
https://doaj.org/article/a85482aa0f754e97bcc000c28f63f8be
Autor:
Jason Gurney, Anna Davies, James Stanley, Laird Cameron, Shaun Costello, Paul Dawkins, Kimiora Henare, Christopher G.C.A. Jackson, Ross Lawrenson, Jesse Whitehead, Jonathan Koea
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSELung cancer is the biggest cancer killer of indigenous peoples worldwide, including Māori people in New Zealand. There is some evidence of disparities in access to lung cancer treatment between Māori and non-Māori patients, but an examinati
Externí odkaz:
https://doaj.org/article/a7391daf825c456b99a52aefc1f652e8
Autor:
Yeojeong Jane So, MbChB, FRACP, Anne Fraser, MA, Gareth Rivalland, MbChB, FRACP, Mark McKeage, PhD, Richard Sullivan, MbChB, FRACP, Laird Cameron, MbChB, FRACP
Publikováno v:
JTO Clinical and Research Reports, Vol 1, Iss 2, Pp 100022- (2020)
Introduction: EGFR tyrosine kinase inhibitors (TKIs) are more effective than chemotherapy in patients with EGFR-mutant NSCLC. Disease progression on EGFR TKI therapy occurs most often owing to acquired resistance from the gain of an EGFR T790M mutati
Externí odkaz:
https://doaj.org/article/10841a044d834af2b8acaf9bacdaa18d
Targeted therapy for advanced anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer
Publikováno v:
Cochrane Database Syst Rev
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the safety and efficacy of anaplastic lymphoma kinase (ALK) inhibitors given as monotherapy to treat advanced ALK‐rearranged non‐small cell lung c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59192b7c21dfa3a127c68ec946f0bed6
https://doi.org/10.1002/14651858.cd013453
https://doi.org/10.1002/14651858.cd013453
Autor:
Mark J. McKeage, Daniel Ng, Amanda Dixon‐McIver, Donald R. Love, Karen L. Sheath, George Laking, Mark Elwood, Richard Sullivan, Prashannata Khwaounjoo, Christopher Lewis, Nicola Kingston, Laird Cameron, Philip Shepherd, Magreet Strauss, Sandar Tin Tin
Publikováno v:
Internal medicine journalReferences. 50(6)
BACKGROUND Lung cancer is a major cause of death in New Zealand. In recent years, targeted therapies have improved outcomes. AIM To determine the uptake of anaplastic lymphoma kinase (ALK) testing, and the prevalence, demographic profile and outcomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ff866678c5d42de9408eb5af56b6692
https://pubmed.ncbi.nlm.nih.gov/31318119
https://pubmed.ncbi.nlm.nih.gov/31318119
Autor:
Laird Cameron, Benjamin Solomon
Publikováno v:
Drugs. 75:1059-1070
Rearrangements of the anaplastic lymphoma kinase (ALK) gene originally discovered nearly 20 years ago in the context of anaplastic large cell lymphoma were identified as oncogenic drivers in a subset of non-small cell lung cancers (NSCLCs) in 2007. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41b7c48d9471c899b901f8551680f35a
https://doi.org/10.1007/s40265-015-0415-9
https://doi.org/10.1007/s40265-015-0415-9
Publikováno v:
Seminars in oncology. 45(5-6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3666b786b51d8d4db00909679f87bddc
https://pubmed.ncbi.nlm.nih.gov/30342871
https://pubmed.ncbi.nlm.nih.gov/30342871
Autor:
Richard Beasley, Janine Pilcher, Mark Bailey, Kyle Perrin, Irene Braithwaite, Andrew Swain, Mark Weatherall, Darren Bowles, Laird Cameron
Publikováno v:
Emergency Medicine Journal. 32:234-238
Background In 2009 the Wellington Free Ambulance implemented an education programme to reduce high concentration oxygen delivery to patients with an acute exacerbation of chronic obstructive pulmonary disease (AECOPD). The aim of this audit was to co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3230b33fcf340f0b22ecc3223adb7f27
https://doi.org/10.1136/emermed-2013-203094
https://doi.org/10.1136/emermed-2013-203094